# Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia

> **NCT00240357** · PHASE4 · WITHDRAWN · sponsor: **AstraZeneca** · enrollment: 1175 (—)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **PROCEDURE:** Lifestyle Regulation

## Key facts

- **NCT ID:** NCT00240357
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1175 (—)
- **Why stopped:** Study cancelled prior to FSI
- **Last updated:** 2009-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00240357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00240357, "Effect of an Internet Based Compliance Enhancement Tool in Subjects With Hypercholesterolemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00240357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*